// JavaScript Document

var Ny = "<p class=\"h3content\">New York</p><p class=\"h3content\"><strong>New York</strong> <strong>University</strong> <strong>College of Dentistry</strong></p><p><strong>Joseph Guttenplan, MS, PhD, </strong>Professor of Basic Sciences (Biochemistry), Director of the Office of  Research Department: Basic Sciences. Dr Guttenplan is a collaborator in the  project estrogen and breast cancer and has been one of the members of the  consortium created for eth breast Cancer Center of Excellence funded by the  Department of Defense.<br /><a href=\"http://www.med.nyu.edu/cgi-bin/oph?name=id%3djbg1\" target=\"top\">more</a></p><p><b>Mary Snow Wolff, PhD</b>, Professor, Community and Preventive Medicine, Professor Oncological Sciences. She is the Co-PI of the Breast Cancer and the Environment Research Center.<br /><a href=\"http://www.mountsinai.org/Find%20A%20Faculty/profile.do?id=0000072500001497126332\" target=\"top\">more</a></p>";

var Oh = '<p class=\"h3content\">Ohio</p><p class="h3content"><strong>University of Cincinnati</strong></p><p><strong>Frank M. Biro, MD</strong>,  is the Director of Education and a Professor of Clinical Pediatrics in the  Division of Adolescent Medicine at Cincinnati Children\'s Hospital. He is  involved in the project Biomarkers of Exposure.<a href="http://www.cincinnatichildrens.org/svc/find-professional/b/frank-biro.htm" target="top">more</a></span></p><p><strong>Susan Pinney, PhD</strong> is an  associate professor at the University of Cincinnati and is involved in the Project Biomarkers of Exposure<br /><a href="http://healthnews.uc.edu/experts/?/2970/2972/" target="top">more</a></p>';

var Mn = '<p class=\"h3content\">Minnesota</p><p><span class="h3content"><b>Mayo Clinic Cancer Center</b></span></p><p><b>Sandhya Pruthi, MD General Internal Medicine</b>, Research interests include chemoprevention of breast cancer using SERMS (tamoxifen, raloxifene), aromatase inhibitors and alternative therapies in women who are at increased risk for breast cancer. She is the principal investigator at Mayo Clinic for multicenter, NCI-Canada sponsored trial MAP-3 (Excel Study) evaluating exemestane versus placebo in postmenopausal women who are at increased risk for developing breast cancer. This is an interdisciplinary effort with the Mayo Clinic Cancer Center. Her other research interests including studying molecular markers present in nipple aspirate, blood and urine that might be useful for diagnosing breast cancer. Dr. Pruthi is the principal investigator of several complementary and alternative therapy trials which include flaxseed for hot flash management and vitamin E and Evening Oil of Primrose for management of cyclical mastalgia.<br /><a href="http://ndc.mayo.edu/mayo/research/staff/pruthi_s.cfm" target="top">more</a></p>';

var Ne = '<p class=\"h3content\">Nebraska</p><p><span class="h3content"><strong>University of Nebraska</strong></span> </p><p><strong>Ercole Cavalieri, DScP</strong> is a Professor in  the Eppley Institute, and Director of the Center for Environmental Toxicology,  Department of Biochemistry and Molecular Biology, Department of Pharmaceutical  Sciences in the University   of Nebraska. Dr.  Cavalieri was the PI of the Breast Cancer  Center of Excellence funded by the Department of Defense and is an important  collaborator in the project Estrogen and Breast Cancer.<br /><a href="http://www.unmc.edu/eppley/faculty/f_caval.htm" target="top">more</a></p>';

var Va = '<p class=\"h3content\">Virginia</p><p class="h3content"><strong>University of Virginia</strong></p><p><strong>Richard Santen, MD</strong>, is Professor of Internal Medicine and Assoc.  Dir. (Clin. Res., Cancer Center) at the University  of Virginia School of Medicine.  Dr. Santen  has been has been a mayor  collaborator in the project Estrogen and Breast Cancer and has been one of the  members of the consortium created for the Breast Cancer Center of Excellence,  funded by the Department of Defense.<br /><a href="http://myprofile.cos.com/rjs5yvirginiaed" target="top">more</a></p>';

var Tx = '<p class=\"h3content\">Texas</p><p><span class="h3content"><strong>Southwestern Medical</strong> <strong>School</strong></span></p><b>David M. Euhus, MD, FACS</b><p>Dr. Euhus’ primary research interests are in the areas of cancer genetics, breast cancer risk assessment and breast cancer prevention. In collaboration with the BayesMendel Group at Johns Hopkins University, he continues to develop his CancerGene program, a software suite for cancer risk assessment and counseling with a special focus on inherited cancer syndromes. His laboratory is actively engaged in identifying markers in breast tissue that could be used to identify women at high risk for breast cancer or that could be used as surrogate endpoints in prevention trials. Most recently his work has focused on DNA methylation, a chemical change in DNA that inappropriately turns off important tumor suppressor genes. These changes are being evaluated in breast cells obtained from high risk women by nipple duct lavage or fine needle aspiration biopsy. Markers of proliferation, programmed cell death and gene expression are also being evaluated as part of a multi-institutional National Cancer Institute-funded chemoprevention trial for which he serves as the principal investigator. His research group is currently exploring mammographic density as a potential marker of breast cancer risk and a potential surrogate endpoint for prevention trials. The ultimate goal of the research program is to discover ways to prevent breast cancer in women who are at high risk for the disease.<br /><a href="http://www.utsouthwestern.edu/findfac/professional/0,,20095,00.html" target="top">more</a></p>';

var Tn='<p class=\"h3content\">Tennessee</p><p class="h3content"><strong>University of Memphis</strong></p><p><strong>Thomas  R. Sutter, PhD</strong>, is Professor and W. Harry Feinstone Chair  of Excellence in Functional Genomics, Director, W. Harry Feinstone Center for  Genomic Research. Dr Sutter has been a major collaborator in the project  Estrogen and Breast Bancer and has been one of the members of the consortium  created for the breast Cancer Center of Excellence funded by the Department of  Defense.<br /><a href="http://biology.memphis.edu/tsutter.html" target="top">more</a></p>';

var Al = '<p class=\"h3content\">Alabama</p><p class="h3content"><strong>University of Alabama <br />at Birmingham</strong> </p><p><strong>Coral  Lamartiniere, PhD,</strong> Director of Pharmacology and Toxicology,  Program Director of Graduate Training Program in Toxicology, Director of  Integrative Biomedical Sciences, Professor of Pharmacology and Toxicology,  Senior Scientist in the UAB Comprehensive  Cancer Center. He is the Co-Pi of the Brest Cancer and the Environment Research   Center and the PI of the  Project Biomarkers of Exposure.<br /><a href="http://main.uab.edu/show.asp?durki=10207" target="top">more</a></p>';

var Bra = '<p class="h3content"><strong>1) University of Campinas, Brazil </strong> </p><p><strong>Maria Luiza S. Mello, PhD</strong>  from the Dept. of Cell Biology – IB,UNICAMP - State University of Campinas, Campinas, Brazil. Dr Mello is a major collaborator in the project estrogen and breast cancer</p><p><strong><a href="http://www.ib.unicamp.br/profs/vidal/sumula.html" target="top">Benedicto C. Vidal, PhD</a></strong> from the Dept. of Cell Biology – IB, UNICAMP - State University of Campinas, Campinas, Brazil. Dr Vidal is a major collaborator in the project estrogen and breast cancer</p><p class="h3content"><strong>2) Ribeirao Preto School of Medicine, Brazil</strong></p><p><strong><a href="http://buscatextual.cnpq.br/buscatextual/visualizacv.jsp?id=K4799356A9" target="top">Daniel Tiezzi, MD, PhD</a></strong>, is Assistant Professor in Department of Gynecology and Obstetrics – Breast Disease Division – Ribeirão Preto School of Medicine, University of Ribeirão Preito,  São Paulo, Brazil. Dr Tiezzi is a major collaborator in the project estrogen and breast cancer.</p><p class="h3content"><strong>4) Federal University of São Paulo, SP, Brazil</strong></p><p><strong>Ismael Dale Cotrim Guerreiro da Silva, MD, PhD</strong>, is head of the Molecular Gynecology Laboratory in the Federal University  of São Paulo, SP, Brazil.  Dr. da Silva is a major contributor and long lasting collaborator with the  BRCL. He is engaged in the project : Use of r-hCG in Women with Primary Breast  Cancer.</p>';

var Ice = '<p class=\"h3content\">Iceland</p><p class="h3content"><strong>Icelandic Tumor Registry, </strong></p><p><strong>Laufey  Tryggvadóttir, MD</strong> is a senior member of the Icelandic Tumor  Register, Reykjavik , Iceland. Dr. Tryggvadóttir, is a  major collaborator in the study of Biomarkers of Breast Cancer Prevention.</p>';

var Nor = '<p class=\"h3content\">Norway</p><p class="h3content"><strong>University of Tromso in Norway</strong></p><p><strong>Inger Gram, MD, Ph.D.</strong>, Professor of the  University of Tromsö, Norway. Dr. Gram is a major  collaborator in the study of Biomarkers of Breast Cancer Prevention.</p>';

var Swe = '<p class=\"h3content\">Sweden</p><p class="h3content"><strong>Under Construction.</strong></p>';

var Be = '<p class=\"h3content\">Belgium</p><p class="h3content"><strong>University of Hasselt, Belgium</strong></p><p><strong>Jaak Ph. Janssens, MD, PhD,</strong> is the Chairman of  the European Cancer Prevention Organization, Hasselt, Belgium.  Dr Janssens is a major collaborator in the project: Use of r-hCG in Women with  Primary Breast Cancer.</p>';

var Tur = '<p class=\"h3content\">Turkey</p><p class="h3content"><strong>Under Construction.</strong></p>';

function showText(mapID, areaID) {
document.getElementById(mapID).innerHTML = areaID;
}